These results showed that downregulation of Sam68 reduces the drug sensitivity of sunitinib, weakens the tumor growth inhibition effect of sunitinib by inhibiting cell apoptosis both in vitro and in vivo. This evidence concerns the gene KHDRBS1 and neoplasm.